Highly active antiretroviral therapy (HAART) suppresses viral loads in 71% of people living with HIV globally, while failing to bring adequate immune reconstitution in nearly one-third of them. We hypothesize that the persistence of latent HIV reservoirs in specific memory T cell subsets contributes to impaired immune recovery. We conducted a case-control study to estimate differences in the HIV-1 proviral DNA across memory CD4-positive T cell subsets between participants with CD4 counts of over 500 cells/µL (immune responders or IRs) and those with counts of less than 350 cells/µL (immune non-responders or INRs) with sustained viral suppression. Latent HIV reservoirs (LRs) were detected in at least one memory T cell subset in 48.33% of total participants. Latent reservoirs were more frequent among INRs than among IRs (65.38% versus 35.29%, P = 0.02), particularly in the effector memory T cell subset (34.6% in INRs versus 8.8% in IRs, P = 0.02). Thus, despite long-term viral suppression with HAART, the persistence of latent reservoirs in memory T cells is associated with poor CD4-positive T cell recovery. Emerging classes of antiretroviral agents that target latent viral pools may enhance immune restoration and bring us closer to finding an HIV cure.
inStem (Institute for Stem Cell Science and Regenerative Medicine)


